(Q54035916)

24 May 2018

title

Differential growth inhibition by 5-fluorouracil in human colorectal carcinoma cell lines. (English)

1 reference

24 May 2018

1 reference

1 reference

Tokunaga E

1

1 reference

24 May 2018

Oda S

2

1 reference

24 May 2018

Fukushima M

3

1 reference

24 May 2018

Maehara Y

4

1 reference

24 May 2018

Sugimachi K

5

1 reference

24 May 2018

publication date

1 October 2000

1 reference

24 May 2018

European Journal of Cancer

published in

1 reference

24 May 2018

volume

36

1 reference

24 May 2018

issue

15

1 reference

24 May 2018

page(s)

1998-2006

1 reference

24 May 2018

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Fluorouracil: biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Metabolism and mechanism of action of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

P-glycoprotein and multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

DNA damage tolerance, mismatch repair and genome instability

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Mechanism of DNA-dependent protein kinase inhibition by cis-diamminedichloroplatinum(II)-damaged DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Interactive effects of inhibitors of poly(ADP-ribose) polymerase and DNA-dependent protein kinase on cellular responses to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Poly(ADP-ribosylation) reduces the steady-state level of breaks in DNA following treatment of human cells with alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

p53 mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Proliferative activation of quiescent Rat-1A cells by delta FosB.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

High-pressure liquid chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Tumor resistance to antimetabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Checkpoint pathways come of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Cellular responses to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Genetic and crystallographic studies of the 3',5'-exonucleolytic site of DNA polymerase I.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

A simplified HPLC method for simultaneously quantifying ribonucleotides and deoxyribonucleotides in cell extracts or frozen tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Mechanisms and biological effects of mismatch repair

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900200-8

7 January 2021

10.1016/S0959-8049(00)00200-8

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018